1. Home
  2. VXRT vs RILY Comparison

VXRT vs RILY Comparison

Compare VXRT & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VXRT
  • RILY
  • Stock Information
  • Founded
  • VXRT N/A
  • RILY 1973
  • Country
  • VXRT United States
  • RILY United States
  • Employees
  • VXRT N/A
  • RILY N/A
  • Industry
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • RILY Investment Managers
  • Sector
  • VXRT Health Care
  • RILY Finance
  • Exchange
  • VXRT Nasdaq
  • RILY Nasdaq
  • Market Cap
  • VXRT 119.0M
  • RILY 142.1M
  • IPO Year
  • VXRT N/A
  • RILY 2007
  • Fundamental
  • Price
  • VXRT $0.34
  • RILY $3.16
  • Analyst Decision
  • VXRT Strong Buy
  • RILY
  • Analyst Count
  • VXRT 2
  • RILY 0
  • Target Price
  • VXRT $3.00
  • RILY N/A
  • AVG Volume (30 Days)
  • VXRT 2.0M
  • RILY 858.4K
  • Earning Date
  • VXRT 05-12-2025
  • RILY 04-29-2025
  • Dividend Yield
  • VXRT N/A
  • RILY 17.86%
  • EPS Growth
  • VXRT N/A
  • RILY N/A
  • EPS
  • VXRT N/A
  • RILY N/A
  • Revenue
  • VXRT $28,700,000.00
  • RILY $854,383,000.00
  • Revenue This Year
  • VXRT N/A
  • RILY N/A
  • Revenue Next Year
  • VXRT N/A
  • RILY N/A
  • P/E Ratio
  • VXRT N/A
  • RILY N/A
  • Revenue Growth
  • VXRT 288.94
  • RILY N/A
  • 52 Week Low
  • VXRT $0.28
  • RILY $2.67
  • 52 Week High
  • VXRT $1.07
  • RILY $40.09
  • Technical
  • Relative Strength Index (RSI)
  • VXRT 35.97
  • RILY 39.62
  • Support Level
  • VXRT $0.28
  • RILY $2.74
  • Resistance Level
  • VXRT $0.38
  • RILY $3.44
  • Average True Range (ATR)
  • VXRT 0.04
  • RILY 0.34
  • MACD
  • VXRT 0.01
  • RILY -0.02
  • Stochastic Oscillator
  • VXRT 40.00
  • RILY 37.69

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

About RILY B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

Share on Social Networks: